
European Organisation for Research and Treatment of Cancer (EORTC)/LinkedIn
Aug 30, 2025, 15:17
Virginia Delucchi Presented Poster at the ISCB46 Conference – EORTC
European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
”We’re thrilled to share that Virginia Delucchi presented her poster at the ISCB46 Conference in Basel!
Her study, “Discontinuation and attrition rates in phase II or phase III first-line randomised clinical trials (RCTs) of solid tumours”, analysed over 500 trials and revealed that while treatment discontinuation is commonly reported, post-study treatment data is often missing, potentially leading to misinterpretation of treatment effects.
This work highlights the urgent need for better reporting practices to ensure transparency and reliability in cancer research.”
More posts featuring EORTC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 30, 2025, 15:17
Aug 30, 2025, 15:13
Aug 30, 2025, 15:07
Aug 30, 2025, 15:04
Aug 30, 2025, 14:53
Aug 30, 2025, 14:41
Aug 30, 2025, 14:40